Hinge Bio, Inc., a privately-held biotechnology company, today announced the close of a Series A’ financing led by Point72. Joining Point72 are Ridgeback Capital, InVivium Capital, and Lightswitch ...
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...
Eight years of work. A collaboration between the Laboratory of Neuroethology of Non-Human Primates of the Department of Medicine and Surgery of the University of Parma, led by Luca Bonini, and a team ...
PRNewswire/ -- healthOme®, Inc., a pioneering genomics-based precision health management company, today announced its renaming and rebranding to Kadance, Inc. This transformative step embodies the ...
The Delhi High Court has directed unidentified parties to remove deepfake videos on social media that featured the trademark of Medanta Hospital and its chairma ...